Works in Neuro-Oncology, 2021, Vol 23
Results: 573
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2000, doi. 10.1093/neuonc/noab254
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2127, doi. 10.1093/neuonc/noab253
- Publication type:
- Article
Potential role of carbon ion radiotherapy in chromothripsis-induced medulloblastoma and other malignancies.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 1991, doi. 10.1093/neuonc/noab232
- By:
- Publication type:
- Article
Corrigendum to: Deep learning-based automatic tumor burden assessment of pediatric high-grade gliomas, medulloblastomas, and other leptomeningeal seeding tumors.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2124, doi. 10.1093/neuonc/noab226
- By:
- Publication type:
- Article
blood-brain barrier limits the therapeutic efficacy of antibody-drug conjugates in glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 1993, doi. 10.1093/neuonc/noab223
- By:
- Publication type:
- Article
Increasing the scope for 18F-FET PET in pediatric neuro-oncology.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 1998, doi. 10.1093/neuonc/noab221
- By:
- Publication type:
- Article
Changes in the vasculature of human brain tumors: Implications for treatment.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 1995, doi. 10.1093/neuonc/noab220
- By:
- Publication type:
- Article
Will mastering ferroptosis allow treating refractory meningiomas?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 1989, doi. 10.1093/neuonc/noab218
- By:
- Publication type:
- Article
Reply to letter to the editor by Gupta et al: Bone marrow biopsy in patients with PCNSL: relevant or redundant?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2119, doi. 10.1093/neuonc/noab216
- By:
- Publication type:
- Article
Response to letter to the editor by Moudgil-Joshi and Kaliaperumal.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2122, doi. 10.1093/neuonc/noab215
- By:
- Publication type:
- Article
Corrigendum to: Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancer.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2123, doi. 10.1093/neuonc/noab204
- By:
- Publication type:
- Article
Telomerase as a therapeutic target in glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2004, doi. 10.1093/neuonc/noab203
- By:
- Publication type:
- Article
Letter regarding Louis et al: The 2021 WHO Classification of Tumors of the Central Nervous System: A summary.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2120, doi. 10.1093/neuonc/noab190
- By:
- Publication type:
- Article
Bone marrow biopsy in PCNSL: Relevant or redundant?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2117, doi. 10.1093/neuonc/noab185
- By:
- Publication type:
- Article
Erratum to: Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2125, doi. 10.1093/neuonc/noab176
- By:
- Publication type:
- Article
Neurosurgical resection for locally recurrent brain metastasis.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2085, doi. 10.1093/neuonc/noab173
- By:
- Publication type:
- Article
Experimental design of preclinical experiments: number of PDX lines vs subsampling within PDX lines.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2066, doi. 10.1093/neuonc/noab137
- By:
- Publication type:
- Article
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2042, doi. 10.1093/neuonc/noab133
- By:
- Publication type:
- Article
Spatial concordance of DNA methylation classification in diffuse glioma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2054, doi. 10.1093/neuonc/noab134
- By:
- Publication type:
- Article
Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse model.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2028, doi. 10.1093/neuonc/noab127
- By:
- Publication type:
- Article
MEF2C silencing downregulates NF2 and E-cadherin and enhances Erastin-induced ferroptosis in meningioma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2014, doi. 10.1093/neuonc/noab114
- By:
- Publication type:
- Article
value of bone marrow biopsy for staging of patients with primary CNS lymphoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2076, doi. 10.1093/neuonc/noab109
- By:
- Publication type:
- Article
Diagnostic accuracy and clinical impact of [18F]FET PET in childhood CNS tumors.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2107, doi. 10.1093/neuonc/noab096
- By:
- Publication type:
- Article
Erratum to: Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2126, doi. 10.1093/neuonc/noab084
- By:
- Publication type:
- Article
Blood-brain barrier alterations in human brain tumors revealed by genome-wide transcriptomic profiling.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2095, doi. 10.1093/neuonc/noab022
- By:
- Publication type:
- Article
Single-cell transcriptome and genome analysis: A much-needed tool for pituitary neuroendocrine tumor studies.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1803, doi. 10.1093/neuonc/noab205
- By:
- Publication type:
- Article
Clinical trial challenges, design considerations, and outcome measures in rare CNS tumors.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. S30, doi. 10.1093/neuonc/noab209
- By:
- Publication type:
- Article
Rare central nervous system tumors: the path to progress.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. S1, doi. 10.1093/neuonc/noab144
- By:
- Publication type:
- Article
DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. S16, doi. 10.1093/neuonc/noab143
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1818, doi. 10.1093/neuonc/noab237
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1987, doi. 10.1093/neuonc/noab236
- Publication type:
- Article
Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. S4, doi. 10.1093/neuonc/noab183
- By:
- Publication type:
- Article
evolving role of systemic therapy and local, brain-directed treatment in patients with melanoma and brain metastases.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1816, doi. 10.1093/neuonc/noab194
- By:
- Publication type:
- Article
Short reply to "Proton therapy for newly diagnosed glioblastoma: more room for investigation" by R. Press et al.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1982, doi. 10.1093/neuonc/noab193
- By:
- Publication type:
- Article
Hypermutated recurrences: Identifying the clinical relevance.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1805, doi. 10.1093/neuonc/noab192
- By:
- Publication type:
- Article
Reply to: "Assessment of imaging biomarkers in the follow-up of brain metastases after SRS".
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1985, doi. 10.1093/neuonc/noab191
- By:
- Publication type:
- Article
COVID-19 in pediatric cancer: Where are the brain tumors?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1977, doi. 10.1093/neuonc/noab189
- By:
- Publication type:
- Article
Cannabinoids and NF-κB: Hijacking a pro-cancer signal Can Be Done.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1810, doi. 10.1093/neuonc/noab187
- By:
- Publication type:
- Article
Silencing glioblastoma networks to make temozolomide more effective.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1807, doi. 10.1093/neuonc/noab186
- By:
- Publication type:
- Article
Diffuse hemispheric glioma, H3 G34-mutant: Genomic landscape of a new tumor entity and prospects for targeted therapy.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1974, doi. 10.1093/neuonc/noab184
- By:
- Publication type:
- Article
early foray with targeted therapy and inspiring novel approaches to combat adult medulloblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1814, doi. 10.1093/neuonc/noab179
- By:
- Publication type:
- Article
EANO guideline on the diagnosis and management of meningiomas.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1821, doi. 10.1093/neuonc/noab150
- By:
- Publication type:
- Article
Rethinking immunotherapy in meningiomas.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1812, doi. 10.1093/neuonc/noab168
- By:
- Publication type:
- Article
Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1922, doi. 10.1093/neuonc/noab075
- By:
- Publication type:
- Article
Assessment of imaging biomarkers in the follow-up of brain metastases after SRS.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1983, doi. 10.1093/neuonc/noab160
- By:
- Publication type:
- Article
SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1835, doi. 10.1093/neuonc/noab152
- By:
- Publication type:
- Article
SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1845, doi. 10.1093/neuonc/noab172
- By:
- Publication type:
- Article
Proton therapy for newly diagnosed glioblastoma: more room for investigation.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1980, doi. 10.1093/neuonc/noab139
- By:
- Publication type:
- Article
immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1911, doi. 10.1093/neuonc/noab128
- By:
- Publication type:
- Article
Newly established patient-derived organoid model of intracranial meningioma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1936, doi. 10.1093/neuonc/noab155
- By:
- Publication type:
- Article